ARHGAP35 and lung cancer: Overexpression of E-cadherin in nonsmall cell lung cancer cells reduces the activity of RhoA and impairs cell migration, concomitantly with the increased membrane association of p190RhoGAP, an inhibitor of Rho GTPases [130].